However, although these inhibitors have demonstrated excellent efficacies in certain human cancer with no neurotoxicity [75, 77], none have been used as a marketed anticancer agent; thus, further investigation is warranted to in the development of KIF11-based anticancer drugs. The gene discussed is KIF11; the disease is cancer.